Market Cap (In KRW)
443.86 Billion
Revenue (In KRW)
265.12 Billion
Net Income (In KRW)
3.7 Billion
Avg. Volume
265.72 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 14520.0-30400.0
- PE
- -
- EPS
- -
- Beta Value
- 0.415485
- ISIN
- KR7099190001
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Dr. Geun-Sig Cha
- Employee Count
- -
- Website
- http://www.i-sens.com
- Ipo Date
- 2013-01-30
- Details
- i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe. The company was founded in 2000 and is headquartered in Seoul, South Korea.
More Stocks
-
KTKBANKThe Karnataka Bank Limited
KTKBANK
-
192400Cuckoo Holdings Co., Ltd.
192400
-
3929Socialwire Co., Ltd.
3929
-
DMND
-
NATHBIOGENNath Bio-Genes (India) Limited
NATHBIOGEN
-
MCOR
-
PRAJINDPraj Industries Limited
PRAJIND
-
WTON